Methods and compositions for reducing viral genome amounts in a target cell

Details for Australian Patent Application No. 2005240118 (hide)

Owner The Board of Trustees of the Leland Stanford Junior University

Inventors Sarnow, Peter; Lancaster, Alissa M.; Jopling, Catherine L.

Agent FB Rice

Pub. Number AU-B-2005240118

PCT Pub. Number WO2005/107816

Priority 60/568,358 04.05.04 US

Filing date 3 May 2005

Wipo publication date 17 November 2005

Acceptance publication date 8 September 2011

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

C12N 15/113 (2010.01) Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

Event Publications

23 November 2006 PCT application entered the National Phase

  PCT publication WO2005/107816 Priority application(s): WO2005/107816

8 September 2011 Application Accepted

  Published as AU-B-2005240118

22 December 2011 Opposition Lodged

  Santaris Pharma A/S has lodged an opposition against The Board of Trustees of the Leland Stanford Junior University.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005240120-Cheese and methods of making such cheese

2005240110-Patient transfer mattress having side pull straps